BMXMF OTC
bioMérieux S.A.
1W: +2.1%
1M: -2.2%
3M: +9.1%
YTD: -34.2%
1Y: -37.0%
3Y: -9.9%
5Y: -29.9%
$85.00
-0.31 (-0.36%)
Weekly Expected Move ±4.2%
$78
$81
$85
$89
$92
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$5.6B
-3.4% ▼
5Y CAGR: +7.2%
Total Liabilities
$1.5B
-5.8% ▼
5Y CAGR: +0.3%
Shareholders Equity
$4.1B
-2.5% ▼
5Y CAGR: +11.0%
Cash & Investments
$570M
+26.6% ▲
5Y CAGR: +7.9%
Total Debt
$461M
-6.0% ▼
5Y CAGR: -0.8%
Net Debt
-$108M
-364.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $804M | $553M | $352M | $450M | $570M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $804M | $553M | $352M | $450M | $570M |
| Net Receivables | $591M | $740M | $729M | $858M | $1.0B |
| Inventory | $635M | $737M | $908M | $1.0B | $959M |
| Other Current Assets | $154M | $155M | $177M | $92M | $0 |
| Total Current Assets | $2.2B | $2.2B | $2.2B | $2.5B | $2.5B |
| Property, Plant & Equip. | $1.2B | $1.4B | $1.5B | $1.7B | $1.7B |
| Goodwill & Intangibles | $1.1B | $1.4B | $1.2B | $1.2B | $1.1B |
| Long-Term Investments | $62M | $91M | $206M | $180M | $129M |
| Other Non-Current Assets | $12M | $13M | $115M | $25M | $10M |
| Total Non-Current Assets | $2.4B | $3.0B | $3.1B | $3.3B | $3.0B |
| Total Assets | $4.6B | $5.2B | $5.3B | $5.8B | $5.6B |
| — Liabilities — | |||||
| Accounts Payable | $240M | $269M | $265M | $272M | $262M |
| Short-Term Debt | $75M | $161M | $136M | $112M | $131M |
| Deferred Revenue | $521M | $552M | $0 | $0 | $0 |
| Other Current Liabilities | $96M | $122M | $280M | $112M | $653M |
| Total Current Liabilities | $956M | $1.1B | $1.1B | $1.1B | $1.1B |
| Long-Term Debt | $265M | $225M | $234M | $207M | $330M |
| Other Non-Current Liab. | $62M | $0 | $53M | $49M | $48M |
| Total Non-Current Liabilities | $486M | $413M | $420M | $424M | $404M |
| Total Liabilities | $1.4B | $1.5B | $1.5B | $1.6B | $1.5B |
| — Equity — | |||||
| Common Stock | $12M | $12M | $12M | $12M | $12M |
| Retained Earnings | $601M | $452M | $358M | $432M | $0 |
| Accumulated OCI | -$23M | $114M | -$18M | $0 | $0 |
| Total Stockholders Equity | $3.1B | $3.6B | $3.8B | $4.2B | $4.1B |
| Total Liabilities & Equity | $4.6B | $5.2B | $5.3B | $5.8B | $5.6B |
| — Key Metrics — | |||||
| Total Debt | $462M | $505M | $519M | $491M | $461M |
| Net Debt | -$341M | -$47M | $166M | $41M | -$108M |
| Total Investments | $62M | $91M | $206M | $180M | $129M |